Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGF and Exercise-induced Ischemia in Muscle Pain
NCT03844243Phase 1Unknown
- Sponsor
- Aalborg University
- Start
- Feb 2019
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Nerve growth factor in hyperalgesia and myalgia (2 arms), sponsored by Aalborg University. Primary endpoint: Pressure Pain Thresholds at 3 weeks. Status: unknown.
02
Drugs
Nerve growth factor
03
Conditions
hyperalgesiamyalgia
Beyond the preview
Go deeper on NCT03844243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844243.